Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `Economics will` |u:www.enterprize.cam.ac.uk.  Search for `Economics will` |u:www.enterprise.cam.ac.uk instead.
1 - 10 of 16 search results for `Economics will` |u:www.enterprise.cam.ac.uk or `Economics will` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. University-led collaboration aims to supercharge UK Social Ventures – …

    https://www.enterprise.cam.ac.uk/news/university-led-collaboration-aims-to-supercharge-uk-social-ventures/
    Thumbnail for University-led collaboration aims to supercharge UK Social Ventures – Cambridge Enterprise 10 Oct 2023: Alongside Oxford University Innovation, who are spearheading the consortium, LSE Innovation (London School of Economics and Political Science’s commercialisation team) will co-lead the project’s training and knowledge dissemination. ... Philippa
  3. reagents Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/reagents/feed/
    28 May 2024: terms of the agreement, Horizon will perform genome engineering on the iPS cells, which will then be differentiated by DefiniGEN. ... will help to improve the efficiency and economics of drug development, and enable the underlying mechanisms of disease
  4. TenUHosts: ecosystems for post-COVID recovery – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tenu-to-host-event-on-the-development-of-entrepreneurial-ecosystems/
    Thumbnail for TenUHosts: ecosystems for post-COVID recovery – Cambridge Enterprise 18 Jan 2021: New York City Economic Development Corporation), will reflect on their experiences of contributing to the development of New York’s entrepreneurial ecosystem and of working within it. ... Paul Drabwell, Deputy Director, Science Research and Innovation,
  5. paul morrill Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/paul-morrill/feed/
    28 May 2024: The project will initially focus on generation of ten iPS-based cell lines for research in areas that currently lack high quality disease models. ... will help to improve the efficiency and economics of drug development, and enable the underlying
  6. Annual Review 2010 From the Pro-Vice-Chancellor(Research) This year…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2009-2010-annual-review-final.pdf
    6 Jan 2011: device will begin in the first half of 2011. 8 Annual Review 2010. ... tomorrow’s transformative discoveries in electronics,energy,healthcare and sustainability will no doubt be.
  7. genomics Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/genomics/feed/
    28 May 2024: will help to improve the efficiency and economics of drug development, and enable the underlying mechanisms of disease to be elucidated in a manner that has previously not been possible.”/p ... ctDNA analysis, which will bring real benefits to
  8. Cambridge joins 11 other universities to launch impact investment…

    https://www.enterprise.cam.ac.uk/news/cambridge-joins-11-other-universities-to-launch-impact-investment-fund/
    Thumbnail for Cambridge joins 11 other universities to launch impact investment fund – Cambridge Enterprise 3 May 2024: The fund will also provide access to timely and expert mission-aligned finance and impact support. ... It will fundraise among alumni networks as well as the wider impact investor community.
  9. genome Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/genome/feed/
    28 May 2024: Horizon will perform genome engineering on the iPS cells, which will then be differentiated by DefiniGEN. ... will help to improve the efficiency and economics of drug development, and enable the underlying mechanisms of disease to be elucidated in a
  10. Horizon Discovery, DefiniGEN collaborate on iPS-based cell lines –…

    https://www.enterprise.cam.ac.uk/news/horizon-discovery-definigen-announce-collaboration-to-develop-gene-engineered-ips-based-cell-lines/
    Thumbnail for Horizon Discovery, DefiniGEN collaborate on iPS-based cell lines – Cambridge Enterprise 22 Feb 2023: These next-generation iPS cell products will help to improve the efficiency and economics of drug development, and enable the underlying mechanisms of disease to be elucidated in a manner that ... Dr Marcus Yeo, CEO, DefiniGEN, commented: “These
  11. Marcus Yeo Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/marcus-yeo/feed/
    28 May 2024: The project will initially focus on generation of ten iPS-based cell lines for research in areas that currently lack high quality disease models. ... will help to improve the efficiency and economics of drug development, and enable the underlying

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.